Synaptic vesicle glycoprotein 2A (SV2A) drugs for Focal Onset Seizures
2 tracked Synaptic vesicle glycoprotein 2A (SV2A) drugs in the Focal Onset Seizures race. The class explanation lives on the Synaptic vesicle glycoprotein 2A (SV2A) page; the full indication pipeline across every mechanism is on the Focal Onset Seizures page.
2 approved / phase 4